Skip to main content

Table 1 Participants’ characteristics at enrollment, Ankazomborona and Matanga Districts, Madagascar, 2018 (n = 344)

From: Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018

 

Ankazomborona

Matanga

ASAQ

(n = 86)

AL

(n = 86)

ASAQ

(n = 86)

AL

(n = 86)

Age (months), median (range)

100 (19–180)

108 (18–178)

72 (8–180)

60 (8–180)

Female, n (%)

37 (43)

34 (40)

41 (48)

42 (49)

Weight (kg), mean, sd

21 (8)

21 (8)

18 (7)

18 (8)

Baseline parasitemia, median parasites/µL (range)

22,293 (1007–88,492)

22,249 (1162–93,915)

11,507 (1093–91,264)

17,445 (1036–94,717)

Gametocytemia on day 0, n (%)

3 (3)

3 (3)

4 (5)

2 (2)

Reached Study end point, n (%)

83 (97)

85 (99)

84 (98)

83 (97)

  1. ASAQ artesunate-amodiaquine, AL artemether-lumefantrine, sd standard deviation